Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 25

Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 26

Insight

May 9, 2024, 00:16

Update CheckMate 9ER summarized by Sergio Cifuentes

Sergio Cifuentes, Cancer Research Project Manager at

“Update CheckMate 9ER
– PFS: 16.6 m vs 8.4 m
– OS: 49.5 m vs 35.5 m (HR 0.70; 95% CI 0.56-0.87)
– CR: 13% vs 5%
– ORR: 56% (50-62%) vs 28% (23-33%)
– mDoR: 22.1 m vs 16.1 m

Benefit in intermediate/poor
Mexican Participation 35%”

Sergio Cifuentes

Proceed to the article.
Source: Sergio Cifuentes/X

cancer cancer therapy CheckMate 9ER clinical trial CR healthcare mDoR Medical Research Mexican participation OncoDaily Oncology ORR OS PFS Sergio Cifuentes treatment outcomes

Sep 4, 2024, 12:44

Lung Cancer Policy Network at WCLC

Sep 4, 2024, 12:38

ASCO endorsed CPOEM Foundation webinar on managing Head and Neck Cancers

Sep 4, 2024, 12:32

Avirup Guha: Our abstract at ESC Congress 2024 on Rurality and outcomes in prostate cancer

Sep 4, 2024, 11:56

Darcy Burbage: Let’s support families impacted by childhood cancer

Sep 4, 2024, 11:52

Frequently asked questions about biomarker testing in NSCLC - LUNGevity Foundation

Sep 4, 2024, 11:47

Dr. Benjamin Schlechter on Botensilimab: Practice-changing Drug | Most Promising Cancer Drugs 2024

Sep 4, 2024, 11:43

Rochelle G Prosser: I am excited to speak about Precision Oncology at the FNIH's Team Science Day

Sep 4, 2024, 11:31

Fabio Moraes: Thrilled to see Dr. Gouveia presenting two papers at WCLC24

Sep 4, 2024, 11:19

OncoInfluencers to Follow on Social Media: Dr. Rachel Riechelmann

Sep 4, 2024, 11:18

ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours

Sep 4, 2024, 10:54

Article of the day, September 4th, suggested by the Immune Oncology Research Institute

Sep 4, 2024, 10:49

Highlighting the challenges myeloma patients face around clinical trials